Literature DB >> 10862760

Insulin responsiveness of the glucagon gene conferred by interactions between proximal promoter and more distal enhancer-like elements involving the paired-domain transcription factor Pax6.

R Grzeskowiak1, J Amin, E Oetjen, W Knepel.   

Abstract

Regulation of gene transcription is an important aspect of insulin's action. However, the mechanisms involved are poorly understood. Insulin inhibits glucagon gene transcription, and insulin deficiency is associated with hyperglucagonemia that contributes to hyperglycemia in diabetes mellitus. Transfecting glucagon-reporter fusion genes into a glucagon-producing pancreatic islet cell line, a 5'-, 3'-, and internal deletion analysis, and oligonucleotide cassette insertions failed in the present study to identify a single insulin-responsive element in the glucagon gene. They rather indicate that insulin responsiveness depends on the presence of both proximal promoter elements and more distal enhancer-like elements. When the paired domain transcription factor Pax6 binding sites within the proximal promoter element G1 and the enhancer-like element G3 were mutated into GAL4 binding sites, the expression of GAL4-Pax6 and GAL4-VP16 restored basal activity, whereas only GAL4-Pax6 restored also insulin responsiveness. Likewise, GAL4-CBP activity was inhibited by insulin within the glucagon promoter context. The results suggest that insulin responsiveness is conferred to the glucagon gene by the synergistic interaction of proximal promoter and more distal enhancer-like elements, with Pax6 and its potential coactivator the CREB-binding protein being critical components. These data thereby support concepts of insulin-responsive element-independent mechanisms of insulin action to inhibit gene transcription.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10862760     DOI: 10.1074/jbc.M000984200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  CTCF mediates effect of insulin on glucagon expression.

Authors:  Shanli Tsui; Jie Gao; Charles Wang; Luo Lu
Journal:  Exp Cell Res       Date:  2012-03-08       Impact factor: 3.905

2.  The effect of haplotype variation in the bovine PAX6 gene.

Authors:  Yong-Zhen Huang; Yong-Jie Jing; Tian-Bao Wei; Xian-Yong Lan; Chu-Zhao Lei; Chun-Lei Zhang; Hong Chen
Journal:  Mol Biol Rep       Date:  2013-09-27       Impact factor: 2.316

3.  The activation of the rat insulin gene II by BETA2 and PDX-1 in rat insulinoma cells is repressed by Pax6.

Authors:  Gabriele Wolf; Behnam Hessabi; Anke Karkour; Ulrike Henrion; Meike Dahlhaus; Annett Ostmann; Bernd Giese; Martin Fraunholz; Piotr Grabarczyk; Robert Jack; Reinhard Walther
Journal:  Mol Endocrinol       Date:  2010-10-13

4.  Loss of insulin-induced inhibition of glucagon gene transcription in hamster pancreatic islet alpha cells by long-term insulin exposure.

Authors:  M González; U Böer; C Dickel; T Quentin; I Cierny; E Oetjen; W Knepel
Journal:  Diabetologia       Date:  2008-09-02       Impact factor: 10.122

5.  Paired box 6 (PAX6) regulates glucose metabolism via proinsulin processing mediated by prohormone convertase 1/3 (PC1/3).

Authors:  J H Wen; Y Y Chen; S J Song; J Ding; Y Gao; Q K Hu; R P Feng; Y Z Liu; G C Ren; C Y Zhang; T P Hong; X Gao; L S Li
Journal:  Diabetologia       Date:  2008-11-26       Impact factor: 10.122

6.  Inhibition of human insulin gene transcription by peroxisome proliferator-activated receptor gamma and thiazolidinedione oral antidiabetic drugs.

Authors:  S Schinner; R Krätzner; D Baun; C Dickel; R Blume; E Oetjen
Journal:  Br J Pharmacol       Date:  2009-03-26       Impact factor: 8.739

Review 7.  Something old, something new and something very old: drugs for treating type 2 diabetes.

Authors:  D Kaiser; E Oetjen
Journal:  Br J Pharmacol       Date:  2014-06       Impact factor: 8.739

8.  Mutation analysis of PAX6 in inherited and sporadic aniridia from northeastern China.

Authors:  Yang Kang; Ying Lin; Xue Li; Qiong Wu; Lei Huang; Qingjun Li; Qi Hu
Journal:  Mol Vis       Date:  2012-06-27       Impact factor: 2.367

Review 9.  Epigenetic Editing: targeted rewriting of epigenetic marks to modulate expression of selected target genes.

Authors:  Marloes L de Groote; Pernette J Verschure; Marianne G Rots
Journal:  Nucleic Acids Res       Date:  2012-09-21       Impact factor: 16.971

10.  Cross-species microarray analysis with the OSCAR system suggests an INSR->Pax6->NQO1 neuro-protective pathway in aging and Alzheimer's disease.

Authors:  Yue Lu; Xin He; Sheng Zhong
Journal:  Nucleic Acids Res       Date:  2007-06-01       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.